AEON BIOPHARMA INC - *W EXP 07/21/202 (AEONWS)

CUSIP: 00791X118

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / *W EXP 07/21/202
Total 13F shares
2,278,641
Share change
-2,306,562
Total reported value
$3,327,456
Price per share
$1.45
Number of holders
28
Value change
-$609,355
Number of buys
3
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 00791X118?
CUSIP 00791X118 identifies AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AEON BIOPHARMA INC - *W EXP 07/21/202 (AEONWS) as of Q1 2024

As of 31 Mar 2024, AEON BIOPHARMA INC - *W EXP 07/21/202 (AEONWS) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,278,641 shares. The largest 10 holders included Davidson Kempner Capital Management LP, LMR Partners LLP, WOLVERINE ASSET MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., ARISTEIA CAPITAL, L.L.C., D. E. Shaw & Co., Inc., Q Global Advisors, LLC, Hudson Bay Capital Management LP, WHITEBOX ADVISORS LLC, and Calamos Advisors LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.